Stereotactic radiosurgery boost to the resection cavity for cerebral metastases: Report of overall survival, complications, and corticosteroid protocol

Surgical Neurology International

Volumn 4, Issue SUPPL.6, 2013, Pages

  Kellogg, Robert ^a   Straus, David ^a   Choi, Mehee ^b   Chaudhry, Thymur ^c   Diaz, Aidnag ^d   Muñoz, Lorenzo ^a  

^a Departments of Neurosurgery   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cerebral metastases; corticosteroids; stereotactic radiosurgery

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE;

ADD ON THERAPY; ADULT; ARTICLE; BEDTIME DOSAGE; BRAIN METASTASIS; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DEEP VEIN THROMBOSIS; DEPRESSION; DIPLOPIA; DISEASE COURSE; DRUG RESPONSE; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEMIPARESIS; HUMAN; HYPERGLYCEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MYOPATHY; OROPHARYNX CANDIDIASIS; OVERALL SURVIVAL; PERIPHERAL EDEMA; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PSYCHOSIS; RADIATION DOSE; RECURRENT DISEASE; STEREOTACTIC RADIOSURGERY; SUBDURAL HEMATOMA; SURGICAL INFECTION; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; WOUND HEALING IMPAIRMENT;

EID: 84893041587     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.121632     Document Type: Article

References (56)

1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Deep venous thrombosis plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006;295:2483-91.
2. Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM. Steroid myopathy in cancer patients. Neurology 1997;48:1234-8.
3. Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, et al. Central nervous system cancers. J Natl Compr Canc Netw 2011;9:352-400.
4. Chamberlin P, Meyer WJ 3rd. Management of pituitary-adrenal suppression secondary to corticosteroid therapy. Pediatrics 1981;67:245-51.
5. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 2009;10:1037-44.
6. Do L, Pezner R, Radany E, Liu A, Staud C, Badie B. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases. Int J Radiat Oncol 2009;73:486-91.
7. Elliott RE, Rush S, Morsi A, Mehta N, Spriet J, Narayana A, et al. Neurological complications and symptom resolution following Gamma Knife surgery for brain metastases 2 cm or smaller in relation to eloquent cortices. J Neurosurg 2010;113 Suppl: S53-64.
8. Galicich JH, French LA, Melby JC. Use of dexamethasone in treatment of cerebral edema associated with brain tumors. J Lancet 1961;81:46-53.
9. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
10. Gaspar LE, Mehta MP, Patchell RA, Burri SH, Robinson PD, Morris RE, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2009;96:17-32.
11. Hartford AC, Paravati AJ, Spire WJ, Li Z, Jarvis LA, Fadul CE, et al. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: Potential role of preoperative tumor size. Int J Radiat Oncol Biol Phys 2013;85:650-5.
12. Hempen C, Weiss E, Hess C. Dexamethasone treatment in patients with brain metastases and primary brain tumors: Do the benefi ts outweigh the side-effects? Support Care Cancer 2002;10:322-8.
13. Hoskin PJ, Crow J, Ford HT. The infl uence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 1990;19:111-5.
14. Hwang SW, Abozed MM, Hale A, Eisenberg RL, Dvorak T, Yao K, et al. Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: A 9-year retrospective cohort study. J Neurooncol 2010;98:77-82.
15. Ito U, Reulen HJ, Tomita H, Ikeda J, Saito J, Maehara T. Formation and propagation of brain oedema fl uid around human brain metastases. A CT Study. Acta Neurochir (Wien) 1988;90:35-41.
16. Iwai Y, Yamanaka K, Yasui T. Boost radiosurgery for treatment of brain metastases after surgical resections. Surg Neurol 2008;69:181-6; discussion 186.
17. Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, et al. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg 2011;114:1585-91.
18. Kaal EC, Taphoorn MJ, Vecht CJ. Symptomatic management and imaging of brain metastases. J Neurooncol 2005;75:15-20.
19. Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, et al. The role of surgical resection in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2009;96:33-43.
20. Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, et al. The role of surgical resection in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2009;96:33-43.
21. Kaplan IW, Meier R. Submucous lipoma of the colon. Am J Gastroenterol 1959;31:673-83.
22. Karlovits BJ, Quigley MR, Karlovits SM, Miller L, Johnson M, Gayou O, et al. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: Challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 2009;27:E7.
23. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Radiosurgery with or without whole-brain radiotherapy for brain metastases. Am J Clin Oncol 2005;28:173-9.
24. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2009;96:45-68.
25. Maldaun MV, Aguiar PH, Lang F, Suki D, Wildrick D, Sawaya R. Radiosurgery in the treatment of brain metastases: Critical review regarding complications. Neurosurg Rev 2008;31:1-8; discussion 8-9.
26. McGirt MJ, Chaichana KL, Gathinji M, Attenello F, Than K, Ruiz AJ, et al. Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery 2008;63:286-91; discussion 291.
27. Millar BM, Bezjak A, Tsao M, Sturdza A, Laperriere N. Defi ning the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases. Clin Oncol (R Coll Radiol) 2004;16:339-44.
28. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, et al. Stereotactic radiosurgery for brain metastases: Analysis of outcome and risk of brain radionecrosis. Radiat Oncol 2011;6:48.
29. Mintz A, Perry J, Spithoff K, Chambers A, Laperriere N. Management of single brain metastasis: A practice guideline. Curr Oncol 2007;14:131-43.
30. Munoz L, Kellogg R. Selective excision of cerebral metastases from the precentral gyrus. Surg Neurol Int 2013;4:66.
31. Ogiwara H, Kalakota K, Rakhra SS, Helenowski IB, Marymont MH, Kalapurakal JA, et al. Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases. J Neurooncol 2012;108:141-6.
32. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
33. Order SE, Hellman S, Von Essen CF, Kligerman MM. Improvement in quality of survival following whole-brain irradiation for brain metastasis. Radiology 1968;91:149-53.
34. Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW. Reevaluation of surgery for the treatment of brain metastases: Review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005;56:1021-34; discussion 1021-34.
35. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA 1998;280:1485-9.
36. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
37. Rava P, Leonard K, Sioshansi S, Curran B, Wazer DE, Cosgrove GR, et al. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery. J Neurosurg 2013;119:457-62.
38. Robbins JR, Ryu S, Kalkanis S, Cogan C, Rock J, Movsas B, et al. Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis. Neurosurgery 2012;71:937-43.
39. Ross DA, Cetas JS. Steroid psychosis: A review for neurosurgeons. J Neurooncol 2012;109:439-47.
40. Ryan R, Booth S, Price S. Corticosteroid-use in primary and secondary brain tumour patients: A review. J Neurooncol 2011;106:449-59.
41. Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, et al. The role of steroids in the management of brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2009;96:103-14.
42. Salvetti DJ, Nagaraja TG, McNeill IT, Xu Z, Sheehan J. Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain. J Neurosurg 2013;118:1250-7.
43. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998;42:1044-55; discussion 1055-6.
44. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000;47:291-8.
45. Soffi etti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: Report of an EFNS Task Force. Eur J Neurol 2006;13:674-81.
46. Soltys SG, Adler JR, Lipani JD, Jackson PS, Choi CY, Puataweepong P, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008;70:187-93.
47. Sturdza A, Millar BA, Bana N, Laperriere N, Pond G, Wong RK, et al. The use and toxicity of steroids in the management of patients with brain metastases. Support Care Cancer 2008;16:1041-8.
48. Thomson AH, Tomlinson MJ. Brain metastases and steroid reduction after radiotherapy. Palliat Med 2004;18:665-6.
49. Tsao MN, Khuntia D, Mehta MP. Brain metastases: What's new with an old problem? Curr Opin Support Palliat Care 2012;6:85-90.
50. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2003;57:452-64.
51. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, et al. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery. Ann Neurol 1993;33:583-90.
52. Weissman DE, Dufer D, Vogel V, Abeloff MD. Corticosteroid toxicity in neuro-oncology patients. J Neurooncol 1987;5:125-8.
53. Williams BJ, Suki D, Fox BD, Pelloski CE, Maldaun MV, Sawaya RE, et al. Stereotactic radiosurgery for metastatic brain tumors: A comprehensive review of complications. J Neurosurg 2009;111:439-48.
54. Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Nariai T, Barfod BE, et al. Delayed complications in patients surviving at least 3 years after stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2013;85:53-60.
55. Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Barfod BE, et al. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: Comparing treatment results for 1-4 vs≥5 tumors. J Neurosurg 2013;118:1258-68.
56. Yomo S, Hayashi M. The effi cacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases. J Neurooncol 2013;113:459-65.